ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.20% | 37.03% | 40.24% | 22.77% | 13.75% |
| Total Depreciation and Amortization | 11.43% | 0.75% | 3.05% | 5.27% | 9.42% |
| Total Amortization of Deferred Charges | -7.21% | -6.45% | -5.32% | 0.05% | 9.55% |
| Total Other Non-Cash Items | -17.60% | 9.52% | -18.63% | 90.19% | 97.84% |
| Change in Net Operating Assets | -62.63% | 120.05% | 41.47% | 97.90% | 109.69% |
| Cash from Operations | 25.00% | 37.91% | 36.81% | 54.08% | 102.11% |
| Capital Expenditure | 9.65% | 22.81% | 27.52% | 27.67% | 16.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -4.33% | 82.33% | 79.11% | 97.24% | 86.82% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 178.86% | 81.72% | 82.71% | 96.58% | -34.41% |
| Cash from Investing | 25.85% | 58.18% | 56.86% | 90.51% | 76.74% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -90.19% |
| Total Debt Repaid | 95.21% | 50.74% | 17.78% | -21.43% | -106.17% |
| Issuance of Common Stock | 40.20% | 47.22% | 50.83% | 27.32% | 8.04% |
| Repurchase of Common Stock | -100.36% | -146.54% | -311.99% | -578.43% | -418.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.12% | -9.90% | -9.61% | -9.52% | -9.31% |
| Other Financing Activities | -805.65% | 74.39% | 76.60% | 76.60% | 45.24% |
| Cash from Financing | 45.84% | 8.63% | -19.72% | -456.77% | -364.69% |
| Foreign Exchange rate Adjustments | 1,600.81% | -131.13% | -2,590.22% | 319.33% | 19.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9,174.97% | 6,836.91% | 825.69% | 11,116.37% | 122.85% |